Picture supply: Getty Photos
My funding technique inside my Shares and Shares ISA is principally centred on capturing a number of the main structural tendencies shaping the worldwide financial system. One large shift I’m bullish on over the following 20 years is the rise of autonomous autos and robotaxis.
Right now, most individuals within the UK nonetheless assume the concept of automobiles driving themselves sounds extra like sci-fi than actuality. However this know-how is already well-established in a handful of enormous US cities, the place greater than 10m robotaxi rides have now taken place.
Earlier this week, it was introduced that Waymo shall be bringing its totally autonomous taxi service to London’s roads in 2026. In line with the agency’s information, human drivers are 12 occasions extra more likely to be concerned in injury-causing accidents with pedestrians than its personal robotaxis (which don’t get distracted by telephones, passengers, tiredness, and many others).
Listed here are two S&P 500 shares that supply an opportunity to speculate on this area. I believe each are value contemplating.
Alphabet
Waymo is a part of Alphabet (NASDAQ:GOOG), the tech conglomerate that additionally owns Google and YouTube. Due to this fact, buyers would solely be getting oblique publicity right here as a result of Waymo right now continues to be solely a small a part of the general holding firm.
Nevertheless, it’s a rising half, as a result of Waymo has now pushed over 100m totally autonomous miles on public roads in 5 US cities (Phoenix, San Francisco, Los Angeles, Austin, and Atlanta). It’s increasing to Washington and Miami in 2026.
As such, Waymo already calls itself the “world’s most skilled driver“. And it’s nonetheless very early days.
Now, as a result of Waymo will not be a standalone public firm, its figures aren’t reported independently. They’re bundled into Alphabet’s ‘Different Bets’ section. In Q2, this generated $373m in income, up barely yr on yr, however the working loss was a hefty $1.25bn.
Secure to say, Waymo is burning by a variety of money and isn’t going to be worthwhile for a few years. However Alphabet generates mountains of money, though Google search is going through potential challenges from the rise of ChatGPT.
Rising AV platform
The subsequent inventory is Uber (NYSE:UBER). At first look, the rise of AVs might sound a direct risk. In any case, if shoppers can simply e-book a robotaxi from Waymo, Uber’s platform may slowly grow to be much less related.
Nevertheless, the corporate has partnered with over a dozen AV companies, together with Wayve within the UK, WeRide, Momenta and Baidu’s Apollo Go in Asia, and Could Mobility, Lucid, and Nuro within the US. Waymos are additionally booked by Uber in Atlanta and Austin.
The intention seems to be to make AVs virtually commoditised, whereas maintaining its platform because the place the place individuals go to e-book taxis (robo or in any other case). If driverless taxis show cheaper, this might ultimately drive extra bookings/exercise on Uber’s app.
The elephant within the room right here — for each Waymo and Uber — is Tesla. It’s piloting a special AI-based self-driving know-how, which if profitable could possibly be much more scalable. Tesla’s robotaxis may outcompete Waymo on pricing, whereas ignoring Uber as a accomplice altogether.
The rationale I haven’t included Tesla on this two-stock choice is because of valuation. Proper now, the shares are buying and selling at a sky-high 172 occasions ahead earnings.
For Uber and Alphabet, this determine is within the mid-20s, thereby providing development at a way more cheap value.


**prodentim**
prodentim an advanced probiotic formulation designed to support exceptional oral hygiene while fortifying teeth and gums.
**vittaburn**
vittaburn is a liquid dietary supplement formulated to support healthy weight reduction by increasing metabolic rate, reducing hunger, and promoting fat loss.
**nitric boost**
nitric boost is a dietary formula crafted to enhance vitality and promote overall well-being.
**glucore**
glucore is a nutritional supplement that is given to patients daily to assist in maintaining healthy blood sugar and metabolic rates.
**synaptigen**
synaptigen is a next-generation brain support supplement that blends natural nootropics, adaptogens